Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors

Nature Reviews Molecular Cell Biology

Volumn 17, Issue 12, 2016, Pages 783-797

  Levin, Ellis R ^a   Hammes, Stephen R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR; VITAMIN D RECEPTOR; CELL RECEPTOR;

BLOOD VESSEL; CELL ACTIVATION; CELL MEMBRANE; CELL MIGRATION; CELL NUCLEUS; CYTOPLASM; DNA BINDING; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; GLUCOSE METABOLISM; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HORMONAL REGULATION; HORMONE METABOLISM; HUMAN; NONHUMAN; ORGANOGENESIS; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UTERUS; ANIMAL; GENE EXPRESSION REGULATION; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; CELL NUCLEUS; GENE EXPRESSION REGULATION; HUMANS; PROTEIN TRANSPORT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; SIGNAL TRANSDUCTION;

EID: 84991030712     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm.2016.122     Document Type: Review

References (120)

1. Barkhem T, Nilsson S, & Gustafsson J. A. Molecular mechanisms, physiological consequences and pharmacological implications of estrogen receptor action. Am. J. Pharmacogenomics 4, 19-28 (2004).
2. Selye H. Stress and the general adaptation syndrome. Br. Med. J. 1, 1383-1392 (1950).
3. Lykissas E. D, Kourounakis P, & Selye H. Hepatic intracellular distribution of pregnenolone 16α carbonitrile and its influence on adenyl cyclase activity in rat liver cells. Res. Commun. Chem. Pathol. Pharmacol. 19, 173-176 (1978).
4. Spaziani E, & Szego C. M. Early effects of estradiol and cortisol on water and electrolyte shifts in the uterus of the immature rat. Am. J. Physiol. 197, 355-359 (1959).
5. Szego C. M, & Davis J. S. Adenosine 3?, 5? monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl Acad. Sci. USA 58, 1711-1718 (1967).
6. Pietras R. J, & Szego C. M. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265, 69-72 (1977).
7. Wang Z. Y, Seto H, Fujioka S, Yoshida S, & Chory J. BRI1 is a critical component of a plasma-membrane receptor for plant steroids. Nature 410, 380-383 (2001).
8. Hammes S. R, & Levin E. R. Extranuclear steroid receptors: nature and actions. Endocr. Rev. 28, 726-741 (2007).
9. Sen A, et al. Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. J. Clin. Invest. 122, 2469-2481 (2012).
10. Sen A, et al. Paxillin regulates androgen-And epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J. Biol. Chem. 285, 28787-28795 (2010).
11. Migliaccio A, et al. Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J. 19, 5406-5417 (2000).
12. Migliaccio A, et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-Talk with estrogen receptor. EMBO J. 17, 2008-2018 (1998).
13. Daniel A. R, et al. Progesterone receptor B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1-And estrogen receptor-containing transcription complexes. Oncogene 34, 506-515 (2015).
14. McNamara K. M, Moore N. L, Hickey T. E, Sasano H, & Tilley W. D. Complexities of androgen receptor signalling in breast cancer. Endocr. Relat. Cancer 21, T161-T181 (2014).
15. Simons S. S. Jr, Edwards D. P, & Kumar R. Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges. Mol. Endocrinol. 28, 173-182 (2014).
16. Burns K. A, Li Y, Arao Y, Petrovich R. M, & Korach K. S. Selective mutations in estrogen receptor α D domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms. J. Biol. Chem. 286, 12640-12649 (2011).
17. Shiau A. K, et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95, 927-937 (1998).
18. Lubahn D. B, et al. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl Acad. Sci. USA 90, 11162-11166 (1993).
19. Lydon J. P, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9, 2266-2278 (1995).
20. Pappas T. C, Gametchu B, & Watson C. S. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 9, 404-410 (1995).
21. Norfleet A. M, Thomas M. L, Gametchu B, & Watson C. S. Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140, 3805-3814 (1999).
22. Razandi M, Pedram A, Greene G. L, & Levin E. R. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol. Endocrinol. 13, 307-319 (1999).
23. Pedram A, Razandi M, & Levin E. R. Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 20, 1996-2009 (2006).
24. Kousteni S, et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298, 843-846 (2002).
25. Li L, Haynes M. P, & Bender J. R. Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc. Natl Acad. Sci. USA 100, 4807-4812 (2003).
26. Wang Z, et al. A variant of estrogen receptor-α, hER α36: transduction of estrogen-And antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Natl Acad. Sci. USA 103, 9063-9068 (2006).
27. Nilsson S, et al. Mechanisms of estrogen action. Physiol. Rev. 81, 1535-1565 (2001).
28. Flouriot G, Griffin C, Kenealy M, Sonntag-Buck V, & Gannon F. Differentially expressed messenger RNA isoforms of the human estrogen receptor-α gene are generated by alternative splicing and promoter usage. Mol. Endocrinol. 12, 1939-1954 (1998).
29. Pedram A, et al. A conserved mechanism for steroid receptor translocation to the plasma membrane. J. Biol. Chem. 282, 22278-22288 (2007).
30. Lutz L. B, et al. Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation. Proc. Natl Acad. Sci. USA 98, 13728-13733 (2001).
31. Lutz L. B, Kim B, Jahani D, & Hammes S. R. G protein βγ subunits inhibit nongenomic progesterone-induced signaling and maturation in Xenopus laevis oocytes. Evidence for a release of inhibition mechanism for cell cycle progression. J. Biol. Chem. 275, 41512-41520 (2000).
32. Evaul K, Jamnongjit M, Bhagavath B, & Hammes S. R. Testosterone and progesterone rapidly attenuate plasma membrane Gβγ-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors. Mol. Endocrinol. 21, 186-196 (2007).
33. Sen A, & Hammes S. R. Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol. Endocrinol. 24, 1393-1403 (2010).
34. Sen A, et al. Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA 125b expression. Proc. Natl Acad. Sci. USA 111, 3008-3013 (2014).
35. Ballare C, et al. Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c Src/Erk pathway in mammalian cells. Mol. Cell. Biol. 23, 1994-2008 (2003).
36. Boonyaratanakornkit V, et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c Src family tyrosine kinases. Mol. Cell 8, 269-280 (2001).
37. Nemere I, et al. Ribozyme knockdown functionally links a 1, 25(OH)2D3 membrane binding protein (1, 25D3 MARRS) and phosphate uptake in intestinal cells. Proc. Natl Acad. Sci. USA 101, 7392-7397 (2004).
38. Mizwicki M. T, & Norman A. W. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci. Signal. 2, re4 (2009).
39. Kalyanaraman H, et al. Nongenomic thyroid hormone signaling occurs through a plasma membrane-localized receptor. Sci. Signal. 7, ra48 (2014).
40. Martin N. P, et al. A rapid cytoplasmic mechanism for PI3 kinase regulation by the nuclear thyroid hormone receptor, TRβ, and genetic evidence for its role in the maturation of mouse hippocampal synapses in vivo. Endocrinology 155 3713-3724 (2014).
41. Filardo E. J, Quinn J. A, Bland K. I, & Frackelton A. R. Jr. Estrogen-induced activation of Erk 1 and Erk 2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-Activation of the epidermal growth factor receptor through release of HB EGF. Mol. Endocrinol. 14, 1649-1660 (2000).
42. Thomas P, Pang Y, Filardo E. J, & Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146, 624-632 (2005).
43. Revankar C. M, Cimino D. F, Sklar L. A, Arterburn J. B, & Prossnitz E. R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 1625-1630 (2005).
44. Otto C, et al. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 149 4846-4856 (2008).
45. Isensee J, et al. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 150, 1722-1730 (2009).
46. Otto C, et al. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol. Reprod. 80, 34-41 (2009).
47. Albanito L, et al. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 67, 1859-1866 (2007).
48. Madak-Erdogan Z, et al. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol. Endocrinol. 22, 2116-2127 (2008).
49. Takabe K, et al. Estradiol induces export of sphingosine 1 phosphate from breast cancer cells via ABCC1 and ABCG2. J. Biol. Chem. 285, 10477-10486 (2010).
50. Gaudet H. M, Cheng S. B, Christensen E. M, & Filardo E. J. The G protein coupled estrogen receptor, GPER: the inside and inside-out story. Mol. Cell. Endocrinol. 3, 207-219 (2015).
51. Engmann L, Losel R, Wehling M, & Peluso J. J. Progesterone regulation of human granulosa/luteal cell viability by an RU486 independent mechanism. J. Clin. Endocrinol. Metab. 91, 4962-4968 (2006).
52. Friel A. M, et al. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors. Cancer Lett. 356, 434-442 (2015).
53. Li X, et al. Progesterone receptor membrane component 1 regulates hepcidin biosynthesis. J. Clin. Invest. 126, 389-401 (2016).
54. Zhu Y, Bond J, & Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc. Natl Acad. Sci. USA 100, 2237-2242 (2003).
55. Zhu Y, Rice C. D, Pang Y, Pace M, & Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc. Natl Acad. Sci. USA 100, 2231-2236 (2003).
56. Sleiter N, et al. Progesterone receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-releasing hormone release. Endocrinology 150, 3833-3844 (2009).
57. Pi M, et al. Structural and functional evidence for testosterone activation of GPRC6A in peripheral tissues. Mol. Endocrinol. 29, 1759-1773 (2015).
58. Pi M, Parrill A. L, & Quarles L. D. GPRC6A mediates the non-genomic effects of steroids. J. Biol. Chem. 285, 39953-39964 (2010).
59. Razandi M, Pedram A, Merchenthaler I, Greene G. L, & Levin E. R. Plasma membrane estrogen receptors exist and functions as dimers. Mol. Endocrinol. 18, 2854-2865 (2004).
60. Pedram A, Razandi M, Deschenes R. J, & Levin E. R. DHHC 7 and -21 are palmitoylacyltransferases for sex steroid receptors. Mol. Biol. Cell 23, 188-199 (2012).
61. Galluzzo P, Caiazza F, Moreno S, & Marino M. Role of ERβ palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr. Relat. Cancer 14, 153-167 (2007).
62. Acconcia F, et al. Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17β estradiol. Mol. Biol. Cell 16, 231-237 (2005).
63. Razandi M, Pedram A, & Levin E. R. Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane. Mol. Cell. Biol. 30, 3249-3261 (2010).
64. Peffer M. E, et al. Caveolin 1 regulates genomic action of the glucocorticoid receptor in neural stem cells. Mol. Cell. Biol. 34, 2611-2623 (2014).
65. Razandi M, Oh P, Pedram A, Schnitzer J, & Levin E. R. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol. Endocrinol. 16, 100-115 (2002).
66. Kumar P, et al. Direct interactions with Gαi and Gβγ mediate nongenomic signaling by estrogen receptor α. Mol. Endocrinol. 21, 1370-1380 (2007).
67. Razandi M, Pedram A, Park S. T, & Levin E. R. Proximal events in signaling by plasma membrane estrogen receptors. J. Biol. Chem. 278, 2701-2712 (2003).
68. Song R. X, et al. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane. Proc. Natl Acad. Sci. USA 101, 2076-2081 (2004).
69. Galluzzo P, Ascenzi P, Bulzomi P, & Marino M. The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor α-palmitoylation. Endocrinology 149, 2567-2575 (2008).
70. Totta P, Pesiri V, Marino M, & Acconcia F. Lysosomal function is involved in 17β estradiol-induced estrogen receptor α degradation and cell proliferation. PLoS ONE 9, e94880 (2014).
71. Faivre E. J, & Lange C. A. Progesterone receptors upregulate Wnt 1 to induce epidermal growth factor receptor transactivation and c Src-dependent sustained activation of Erk1/2 mitogen-Activated protein kinase in breast cancer cells. Mol. Cell. Biol. 27, 466-480 (2007).
72. Thomas W, & Harvey B. J. Mechanisms underlying rapid aldosterone effects in the kidney. Annu. Rev. Physiol. 73, 335-357 (2011).
73. Grossmann C, Freudinger R, Mildenberger S, Husse B, & Gekle M. EF domains are sufficient for nongenomic mineralocorticoid receptor actions. J. Biol. Chem. 283, 7109-7116 (2008).
74. Le Moellic C, et al. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCα activation, mineralocorticoid receptor phosphorylation, and cross-Talk with the genomic response. J. Am. Soc. Nephrol. 15, 1145-1160 (2004).
75. Weigel N. L, & Moore N. L. Kinases and protein phosphorylation as regulators of steroid hormone action. Nucl. Recept. Signal. 5, e005 (2007).
76. York B, et al. Reprogramming the posttranslational code of SRC 3 confers a switch in mammalian systems biology. Proc. Natl Acad. Sci. USA 107, 11122-11127 (2010).
77. Zheng F. F, Wu R. C, Smith C. L, & O'Malley B. W. Rapid estrogen-induced phosphorylation of the SRC 3 coactivator occurs in an extranuclear complex containing estrogen receptor. Mol. Cell. Biol. 25, 8273-8284 (2005).
78. Jonas B. A, & Privalsky M. L. SMRT and N CoR corepressors are regulated by distinct kinase signaling pathways. J. Biol. Chem. 279, 54676-54686 (2004).
79. Trevino L. S, & Weigel N. L. Phosphorylation: a fundamental regulator of steroid receptor action. Trends Endocrinol. Metab. 24, 515-524 (2013).
80. Wong W. P, et al. Extranuclear estrogen receptor-α stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc. Natl Acad. Sci. USA 107, 13057-13062 (2010).
81. Vazquez-Martin A, et al. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells. Cell Cycle 12, 3471-3477 (2013).
82. Vares G, et al. Progesterone generates cancer stem cells through membrane progesterone receptor-Triggered signaling in basal-like human mammary cells. Cancer Lett. 362, 167-173 (2015).
83. Pedram A, Razandi M, Blumberg B, & Levin E. R. Membrane and nuclear estrogen receptor α collaborate to suppress adipogenesis but not triglyceride content. FASEB J. 30, 230-240 (2016).
84. Pedram A, et al. Estrogen reduces lipid content in the liver exclusively from membrane receptor signaling. Sci. Signal. 6, ra36 (2013).
85. Tiano J. P, et al. Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes. J. Clin. Invest. 121, 3331-3342 (2011).
86. Tiano J. P, & Mauvais-Jarvis F. Molecular mechanisms of estrogen receptors suppression of lipogenesis in pancreatic β-cells. Endocrinology 153, 2997-3005 (2012).
87. Bredfeldt T. G, et al. Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT. Mol. Endocrinol. 24, 993-1006 (2010).
88. Pedram A, Razandi M, Lewis M, Hammes S, & Levin E. R. Membrane-localized estrogen receptor α is required for normal organ development and function. Dev. Cell 29, 482-490 (2014).
89. Pedram A, et al. Estrogen regulates histone deacetylases to prevent cardiac hypertrophy. Mol. Biol. Cell 24, 3805-3818 (2013).
90. Masui K, Cavenee W. K, & Mischel P. S. mTORC2 in the center of cancer metabolic reprogramming. Trends Endocrinol. Metab. 25, 364-373 (2014).
91. Bhatt S, Xiao Z, Meng Z, & Katzenellenbogen B. S. Phosphorylation by p38 mitogen-Activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCF(Skp2) proteasomal complex. Mol. Cell. Biol. 32, 1928-1943 (2012).
92. Reid G, et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 695-707 (2003).
93. Gutierrez-Mecinas M, et al. Long-lasting behavioral responses to stress involve a direct interaction of glucocorticoid receptors with ERK1/2-MSK1-Elk 1 signaling. Proc. Natl Acad. Sci. USA 108, 13806-13811 (2011).
94. Nahar J, et al. Rapid nongenomic glucocorticoid actions in male mouse hypothalamic neuroendocrine cells are dependent on the nuclear glucocorticoid receptor. Endocrinology 156, 2831-2842 (2015).
95. Pedram A, et al. Developmental phenotype of a membrane only estrogen receptor α (MOER) mouse. J. Biol. Chem. 284, 3488-3495 (2009).
96. Mauvais-Jarvis F, Clegg D. J, & Hevener A. L. The role of estrogens in control of energy balance and glucose homeostasis. Endocr. Rev. 34, 309-338 (2013).
97. Soriano S, et al. Rapid regulation of KATP channel activity by 17β estradiol in pancreatic β-cells involves the estrogen receptor β and the atrial natriuretic peptide receptor. Mol. Endocrinol. 23, 1973-1982 (2009).
98. O'Mahony F, Razandi M, Pedram A, Harvey B. J, & Levin E. R. Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells. Mol. Endocrinol. 26, 2058-2070 (2012).
99. Fierz Y, Novosyadlyy R, Vijayakumar A, Yakar S, & LeRoith D. Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression. Diabetes 59, 686-693 (2010).
100. Novosyadlyy R, et al. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res. 70, 741-751 (2010).
101. Pedram A, Razandi M, Aitkenhead M, & Levin E. R. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1. J. Biol. Chem. 280, 26339-26348 (2005).
102. Pedram A, Razandi M, O'Mahony F, Lubahn D, & Levin E. R. Estrogen receptor-β prevents cardiac fibrosis. Mol. Endocrinol. 24, 2152-2165 (2010).
103. Chen Z, et al. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103, 401-406 (1999).
104. Adlanmerini M, et al. Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc. Natl Acad. Sci. USA 111, E283-E290 (2014).
105. Umetani M, et al. 27 Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat. Med. 13, 1185-1192 (2007).
106. Umetani M, & Shaul P. W. 27 Hydroxycholesterol: the first identified endogenous SERM. Trends Endocrinol. Metab. 22, 130-135 (2011).
107. Wu Q, et al. 27 Hydroxycholesterol promotes cell-Autonomous, ER positive breast cancer growth. Cell Rep. 5, 637-645 (2013).
108. Ishikawa T, et al. LXRβ/estrogen receptor-α signaling in lipid rafts preserves endothelial integrity. J. Clin. Invest. 123, 3488-3497 (2013).
109. Lefterova M. I, Haakonsson A. K, Lazar M. A, & Mandrup S. PPARγ and the global map of adipogenesis and beyond. Trends Endocrinol. Metab. 25, 293-302 (2014).
110. Choi J, Park S, & Sockanathan S. Activated retinoid receptors are required for the migration and fate maintenance of subsets of cortical neurons. Development 141, 1151-1160 (2014).
111. Lee C. T, et al. The nuclear orphan receptor COUP-TFII is required for limb and skeletal muscle development. Mol. Cell. Biol. 24, 10835-10843 (2004).
112. Noguchi K. K, Lau K, Smith D. J, Swiney B. S, & Farber N. B. Glucocorticoid receptor stimulation and the regulation of neonatal cerebellar neural progenitor cell apoptosis. Neurobiol. Dis. 43, 356-363 (2011).
113. Atwood C. S, et al. Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J. Endocrinol. 167, 39-52 (2000).
114. Brisken C, & O'Malley B. Hormone action in the mammary gland. Cold Spring Harb. Perspect. Biol. 2, a003178 (2010).
115. Han S. J, et al. Estrogen receptor β modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell 163, 960-974 (2015).
116. Pedram A, Razandi M, Wallace D. C, & Levin E. R. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol. Biol. Cell 17, 2125-2137 (2006).
117. Adzic M, et al. Brain region-And sex-specific modulation of mitochondrial glucocorticoid receptor phosphorylation in fluoxetine treated stressed rats: effects on energy metabolism. Psychoneuroendocrinology 38, 2914-2924 (2013).
118. Lee S. R, et al. Glucocorticoids and their receptors: insights into specific roles in mitochondria. Prog. Biophys Mol. Biol. 112, 44-54 (2013).
119. Simoes D. C, et al. Glucocorticoid and estrogen receptors are reduced in mitochondria of lung epithelial cells in asthma. PLoS ONE 7, e39183 (2012).
120. Razandi M, Pedram A, Jordan V. C, Fuqua S, & Levin E. R. Tamoxifen regulates cell fate through mitochondrial estrogen receptor β in breast cancer. Oncogene 32, 3274-3285 (2013).